Triethylamine → 4-(1-((2-Chloropyridin-3-yl)carbonyl)-4-hydroxypiperidin-4-yl)benzonitrile

HRID 538475Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 538475
[Cl:1][C:2]1[N:10]=[CH:9][CH:8]=[CH:7][C:3]=1[C:4]([OH:6])=O.Cl.C([C:14]1[CH:27]=[CH:26][C:17]([CH2:18][C:19]2([OH:25])[CH2:24][CH2:23][NH:22][CH2:21][CH2:20]2)=C[CH:15]=1)#N.[CH3:28][N:29](C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C(N(CC)CC)C>CN(C=O)C.O>[Cl:1][C:2]1[C:3]([C:4]([N:22]2[CH2:21][CH2:20][C:19]([C:18]3[CH:15]=[CH:14][C:27]([C:28]#[N:29])=[CH:26][CH:17]=3)([OH:25])[CH2:24][CH2:23]2)=[O:6])=[CH:7][CH:8]=[CH:9][N:10]=1

Komponenten

7

Edukt 4

HCID 8471TriethylamineHCID 762582-Chloronicotinic acidHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 866808464-(4-Cyanobenzyl)-4-hydroxypiperidine hydrochloride

Produkt 1

HCID 866808604-(1-((2-Chloropyridin-3-yl)carbonyl)-4-hydroxypiperidin-4-yl)benzonitrileAusbeute 104 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 962WaterLösungsmittelHCID 6228DimethylformamideLösungsmittel

Versuchsvorschrift

A suspension of 2-chloronicotinic acid (0.20 g), 4-(4-cyanobenzyl)-4-hydroxypiperidine hydrochloride (0.32 g), HATU (0.72 g) and triethylamine (0.89 mL) in DMF (4.0 mL) was stirred overnight at room temperature. The reaction mixture was diluted with water, and the mixture was extracted with ethyl acetate. The extract was washed with saturated brine, and dried over anhydrous sodium sulfate, and filtered through basic silica gel. The filtrate was concentrated under reduced pressure to give the title compound (0.45 g).

Aufarbeitung

  1. extractionthe mixture was extracted with ethyl acetate
  2. washThe extract was washed with saturated brine
  3. dry with materialdried over anhydrous sodium sulfate
  4. filtrationfiltered through basic silica gel
  5. concentrationThe filtrate was concentrated under reduced pressure

Quellen und Nachweise

ORD-Eintrag
ord-9531806540ef48679edd3a36921af586
Quelldatensatz
uspto-grants-2014_10
Patentnummer
US08865717B2

Notizen zur Reaktion

Wird geladen…